Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 153
Filtrar
1.
Invest Ophthalmol Vis Sci ; 65(6): 13, 2024 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-38848078

RESUMEN

Purpose: Fungal keratitis (FK) is an invasive corneal infection associated with significant risk to vision. Although the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway has been recognized for its role in defending against viral infections, its involvement in FK still remains largely unclear. This study sought to elucidate the contribution of the cGAS/STING signaling pathway to the pathogenesis of FK. Methods: The expression of cGAS/STING signaling components was assessed in a murine model of Candida albicans keratitis through RNA sequencing, western blot analysis, immunofluorescence staining, and real-time PCR. Both genetic (utilizing Sting1gt/gt mice) and pharmacological (using C176) interventions were employed to inhibit STING activity, allowing for the evaluation of resultant pathogenic alterations in FK using slit-lamp examination, clinical scoring, hematoxylin and eosin (H&E) staining, fungal culture, and RNA sequencing. Subconjunctival administration of the NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor MCC950 was performed to evaluate FK manifestations following STING activity blockade. Furthermore, the impact of the STING agonist diABZI on FK progression was investigated. Results: Compared to uninfected corneas, those infected with C. albicans exhibited increased expression of cGAS/STING signaling components, as well as its elevated activity. Inhibiting cGAS/STING signaling exacerbated the advancement of FK, as evidenced by elevated clinical scores, augmented fungal load, and heightened inflammatory response, including NLRP3 inflammasome activation and pyroptosis. Pharmacological inhibition of the NLRP3 inflammasome effectively mitigated the exacerbated FK by suppressing STING activity. Conversely, pre-activation of STING exacerbated FK progression compared to the PBS control, characterized by increased fungal burden and reinforced inflammatory infiltration. Conclusions: This study demonstrates the essential role of the cGAS/STING signaling pathway in FK pathogenesis and highlights the necessity of its proper activation for the host against FK.


Asunto(s)
Candida albicans , Candidiasis , Modelos Animales de Enfermedad , Infecciones Fúngicas del Ojo , Proteínas de la Membrana , Nucleotidiltransferasas , Transducción de Señal , Animales , Proteínas de la Membrana/metabolismo , Proteínas de la Membrana/genética , Nucleotidiltransferasas/metabolismo , Nucleotidiltransferasas/genética , Infecciones Fúngicas del Ojo/microbiología , Infecciones Fúngicas del Ojo/metabolismo , Ratones , Candida albicans/fisiología , Candidiasis/microbiología , Candidiasis/metabolismo , Ratones Endogámicos C57BL , Reacción en Cadena en Tiempo Real de la Polimerasa , Queratitis/microbiología , Queratitis/metabolismo , Western Blotting , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Femenino , Úlcera de la Córnea/microbiología , Úlcera de la Córnea/metabolismo , Inflamasomas/metabolismo
2.
Exp Eye Res ; 242: 109863, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38494102

RESUMEN

PURPOSE: Pseudomonas aeruginosa-induced keratitis is one of the most severe and challenging forms of corneal infection, owing to its associated intense inflammatory reactions leading to corneal necrosis and dense corneal scar with loss of vision. Since mesenchymal stem cells (MSCs) are reported to possess antimicrobial and immunomodulatory properties, they can be tested as an adjuvant treatment along with the antibiotics which are the current standard of care. This study aims to investigate the anti-bacterial and immunomodulatory roles of human bone marrow MSC-derived conditioned medium (MSC-CM) in P. aeruginosa-infected human corneal epithelial cells (HCECs) in vitro. METHODS: The effect of MSC-CM on the growth of clinical isolates of P. aeruginosa was evaluated by colony-forming unit assay. The expression of inflammatory cytokines (IL-6 and TNF-α) and an antimicrobial peptide (Lipocalin 2) in lipopolysaccharide-treated MSCs and HCECs was analyzed through ELISA. Corneal epithelial repair following infection with P. aeruginosa was studied through scratch assay. RESULTS: Compared to control (P. aeruginosa (5*105) incubated in DMEM (1 ml) at 37 °C for 16 h), MSC-CM significantly: i) inhibits the growth of P. aeruginosa (159*109 vs. 104*109 CFU/ml), ii) accelerates corneal epithelial repair following infection with P. aeruginosa (9% vs. 24% closure of the wounded area after 12 h of infection), and iii) downregulates the lipopolysaccharide-induced expression of IL-6, TNF-α and Lipocalin 2 in HCECs. A combination of MSC-CM with an antibiotic, Ciprofloxacin moderately regulated the expression of IL-6, TNF-α, and Lipocalin 2. CONCLUSION: MSC-CM holds promise as an adjunctive therapeutic approach for P. aeruginosa-induced corneal epithelial damage.


Asunto(s)
Ensayo de Inmunoadsorción Enzimática , Infecciones Bacterianas del Ojo , Células Madre Mesenquimatosas , Infecciones por Pseudomonas , Pseudomonas aeruginosa , Humanos , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/metabolismo , Infecciones Bacterianas del Ojo/patología , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/terapia , Infecciones por Pseudomonas/tratamiento farmacológico , Células Madre Mesenquimatosas/metabolismo , Epitelio Corneal/microbiología , Epitelio Corneal/patología , Epitelio Corneal/metabolismo , Células Cultivadas , Queratitis/microbiología , Queratitis/metabolismo , Queratitis/patología , Trasplante de Células Madre Mesenquimatosas/métodos , Medios de Cultivo Condicionados/farmacología , Prueba de Estudio Conceptual , Interleucina-6/metabolismo , Úlcera de la Córnea/microbiología , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/patología , Úlcera de la Córnea/tratamiento farmacológico , Lipocalina 2/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
3.
Surv Ophthalmol ; 68(5): 929-939, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37352980

RESUMEN

During infectious keratitis, the production of collagenolytic and inflammatory substances, along with increased corneal matrix metalloproteinase (MMP) activity, induces the degradation of corneal collagen and may cause postkeratitis complications, such as opacity, thinning, and corneal perforation. MMPs, especially MMP-2 and MMP-9, are overexpressed in infectious keratitis and sustained over time by inflammatory and nonmicrobial mechanisms. The high MMP levels are correlated with excessive corneal destruction in bacterial, herpetic, fungal, and acanthamoeba infections. Nonspecific treatments, such as tetracyclines, particularly doxycycline, or corticosteroids, are used as adjuvants to antimicrobials to alleviate the disproportionate degradation and inflammation of the corneal layers caused by corneal MMPs and decrease the recruitment and infiltration of inflammatory cells. Treatments showing inhibition of specific MMPs (Galardin, ZHAWOC7726), interfering with pro-MMP activation (EDTA, ascorbic acid), or showing anticytokine effect (epigallocatechin-2-gallate, TRAM-34) have been reported. Other treatments show a direct action over corneal collagen structure such as corneal cross-linking or have been associated with reduction of MMP levels such as amniotic membrane grafting. Although the use of these drugs has been shown in studies to be effective in controlling inflammation, especially in experimental ones, robust studies are still needed based on randomized and randomized clinical trials to demonstrate their potential effect as adjuvants in the management of infectious keratitis.


Asunto(s)
Úlcera de la Córnea , Queratitis , Humanos , Úlcera de la Córnea/tratamiento farmacológico , Úlcera de la Córnea/metabolismo , Queratitis/tratamiento farmacológico , Queratitis/microbiología , Córnea , Inflamación , Colágeno
4.
Cornea ; 42(8): 1005-1015, 2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-37155343

RESUMEN

PURPOSE: The aim of this study was to investigate the effects of indoleamine 2,3-dioxygenase (IDO) on macrophage polarization, phagocytosis, and killing through regulation of the CCL2/CCR2 signaling pathway in Aspergillus fumigatus keratitis. METHODS: In vivo and in vitro experiments were conducted in mice and mouse peritoneal macrophages after infection with A. fumigatus . Clinical scoring, reverse transcription-polymerase chain reaction, and immunofluorescence staining were used to evaluate the fungal keratitis lesions, macrophage-related cytokines, and macrophage recruitment. The expression of CCL2 and CCR2 was detected by reverse transcription-polymerase chain reaction and western blot after pretreatment with or without an IDO inhibitor (1-MT). After pretreatment with 1-MT, a CCR2 antagonist, a CCL2 neutralizing antibody, an IDO agonist (IFNG), and recombinant CCL2 protein (CCL2), the flow cytometry and colony-forming unit counts were used to detect the polarization, phagocytosis, and killing function. RESULTS: Compared with the control group, the infected eyes showed increased clinical scores, macrophage-related cytokine expression, and macrophage recruitment. 1-MT pretreatment increased the expression of CCL2 and CCR2 and the proportion of CD206+/CD86+ macrophages; macrophages polarized toward the M2 type, with enhanced killing function. CCR2 antagonists and CCL2 neutralizing antibodies reversed the effects of 1-MT. Compared with the infected group, IFNG pretreatment decreased the proportion of CD206+/CD86+ macrophages, and macrophages polarized toward the M1 type, with decreased phagocytosis and impaired killing function. CCL2 reversed the effect of IFNG. CONCLUSIONS: IDO can promote the polarization of macrophages to the M1 type by blocking the CCL2/CCR2 signaling pathway, inhibiting the phagocytosis and killing function of macrophages, and mediating the protective immune role of A. fumigatus .


Asunto(s)
Úlcera de la Córnea , Queratitis , Animales , Ratones , Quimiocina CCL2/metabolismo , Quimiocina CCL2/farmacología , Úlcera de la Córnea/metabolismo , Citocinas/metabolismo , Queratitis/patología , Macrófagos/metabolismo , Ratones Endogámicos C57BL , Proteínas Recombinantes , Transducción de Señal , Indolamina-Pirrol 2,3,-Dioxigenasa
5.
Exp Eye Res ; 216: 108960, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35085580

RESUMEN

Fungal keratitis is one of leading reasons for blindness in the world, which causes corneal blindness mainly due to excessive inflammatory responses. Kaempferol (KAE) is a natural flavonoid which has potent anti-inflammatory effects. However, whether KAE plays protective roles in fungal keratitis and the potentially protective mechanisms are unrevealed. Here we first investigated the anti-inflammatory and antifungal effects of KAE on Aspergillus fumigatus (A. fumigatus) keratitis in C57BL/6 mice. We found that treatment of KAE ameliorated the severity of keratitis, inhibited macrophages and neutrophils recruitment, depressed corneal fungal load, and declined the expression of TLR4 and Dectin-1 in A. fumigatus infected mice corneas. And in activated hyphae or Curdlan stimulated macrophages, pretreatment of KAE also significantly decreased the mRNA and protein expression of IL-1ß, TNF-α, MIP-2 and the phosphorylated-p38 (p-p38)/p38 MAPK ratio. In summary, KAE ameliorated the prognosis of fungal keratitis in C57BL/6 mice by reducing corneal fungal load, depressing the inflammatory cells recruitment, and downregulating the expression of inflammatory factors, and those effects depended on the inhibition of Dectin-1 and p38 MAPK pathway.


Asunto(s)
Aspergilosis/tratamiento farmacológico , Aspergillus fumigatus/efectos de los fármacos , Úlcera de la Córnea/tratamiento farmacológico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Quempferoles/uso terapéutico , Lectinas Tipo C/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Animales , Aspergilosis/metabolismo , Aspergilosis/microbiología , Aspergillus fumigatus/fisiología , Recuento de Colonia Microbiana , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Modelos Animales de Enfermedad , Infecciones Fúngicas del Ojo/metabolismo , Infecciones Fúngicas del Ojo/microbiología , Femenino , Macrófagos/fisiología , Ratones , Ratones Endogámicos C57BL , Neutrófilos/fisiología , Pronóstico
6.
Exp Eye Res ; 216: 108941, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35077754

RESUMEN

Fungal keratitis (FK) is one of the main causes of blindness in China. People with diabetes are susceptible to corneal epithelial disease, even fungal keratitis. At present, there are few studies on this disease. Resolvins (Rv) has been reported as a mediators that exert crucial anti-inflammatory and immune regulation roles in serval diseases. In order to investigate the roles and underlying mechanism of Resolvins D1 (RvD1) on the Aspergillus fumigatus (A. fumigatus) keratitis in diabetes, we established in vivo and in vitro models of A. fumigatus keratitis, which were then exposed to high glucose. The expression levels of RvD1, 5-lipoxygenase (5-LOX), and 15-lipoxygenase (15-LOX) in A. fumigatus keratitis patients with diabetes were determined through Enzyme Linked Immunosorbent Assay (ELISA), Western blot and immunohistochemistry. Reactive Oxygen Species (ROS) production, ELISA, flow cytometry, Hematoxylin-Eosin (HE) staining and fungal loading determination were conducted to evaluate the severity of A. fumigatus infection. Lymphangiogenesis and angiogenesis were examined by immunofluorescence assay. Western blot was applied to detect the proteins of the MAPK-NF-κB pathway. The results showed that RvD1 diminished the high glucose-induced oxidative stress and inflammatory response, as evidenced by the reduction of ROS production, Interleukin-6 (IL-6), Interleukin-8 (IL-8), Heme Oxygenase-1 (HMOX-1), and the elevation of Cyclooxygenase-2 (COX2), Superoxide Dismutase (SOD-1), and Glutathione Peroxidase-2 (GPX2) levels in A. fumigatus-infected Human Corneal Endothelial Cells (HCECs). Additionally, lymphangiogenesis and angiogenesis prominently decreased after intervention with RvD1. Furthermore, RvD1 significantly reduced the levels of p-MEK1/2 and p-ERK1/2, and restrained the NF-κB and GPR32 activation. The above results showed that RvD1 protects against A. fumigatus keratitis in diabetes by suppressing oxidative stress, inflammatory response, fungal growth, and immunoreaction via modulating MAPK-NF-κB pathway. RvD1 provides clues for the therapeutic targets of Fungal keratitis complicated with diabetes.


Asunto(s)
Aspergilosis/prevención & control , Úlcera de la Córnea/prevención & control , Complicaciones de la Diabetes/microbiología , Ácidos Docosahexaenoicos/fisiología , Infecciones Fúngicas del Ojo/prevención & control , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , FN-kappa B/metabolismo , Animales , Araquidonato 15-Lipooxigenasa/metabolismo , Araquidonato 5-Lipooxigenasa/metabolismo , Aspergilosis/metabolismo , Aspergilosis/microbiología , Aspergillus fumigatus/fisiología , Western Blotting , Células Cultivadas , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Complicaciones de la Diabetes/metabolismo , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Epitelio Corneal/efectos de los fármacos , Epitelio Corneal/microbiología , Infecciones Fúngicas del Ojo/metabolismo , Infecciones Fúngicas del Ojo/microbiología , Citometría de Flujo , Glucosa/farmacología , Humanos , Inmunohistoquímica , Ratones Endogámicos C57BL , Estrés Oxidativo/efectos de los fármacos , Oxidorreductasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo
7.
Cornea ; 41(7): 894-900, 2022 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-34759205

RESUMEN

PURPOSE: Transcorneal drug delivery is hindered by ocular physical and biochemical properties, such as tear production, the epithelial layer of the cornea, and blinking. The aim of this study was to determine whether ultrasound can be applied to increase the transcorneal drug delivery of natamycin used in the treatment of fungal keratitis without dangerously overheating the surrounding ocular tissues. METHODS: To verify the safety of various sets of ultrasound parameters, modeling studies were conducted using OnScale, an ultrasonic wave modeling software. Ultrasound parameters determined optimal for ocular tissue safety were used in a laboratory setting in a jacketed Franz diffusion cell setup. Histological images of the cross-section of the corneas used in experiments were examined for cell damage under a microscope. RESULTS: Increases in transcorneal drug delivery were seen in every treatment parameter combination when compared with the sham treatment. The highest increase was 4.0 times for 5 minutes of pulsed ultrasound at a 25% duty cycle and a frequency of 400 kHz and an intensity of 0.5 W/cm 2 with statistical significance ( P < 0.001). Histological analysis revealed structural damage only in the corneal epithelium, with most damage being at the epithelial surface. CONCLUSIONS: This study suggests that ultrasound is a safe, effective, and minimally invasive treatment method for enhancing the transcorneal drug delivery of natamycin. Further research is needed into the long-term effects of ultrasound parameters used in this study on human ocular tissues.


Asunto(s)
Úlcera de la Córnea , Infecciones Fúngicas del Ojo , Córnea/metabolismo , Úlcera de la Córnea/diagnóstico por imagen , Úlcera de la Córnea/tratamiento farmacológico , Úlcera de la Córnea/metabolismo , Sistemas de Liberación de Medicamentos/métodos , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Humanos , Natamicina/uso terapéutico
8.
Invest Ophthalmol Vis Sci ; 62(15): 14, 2021 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-34919120

RESUMEN

Purpose: Previously, we demonstrated that miR-183/96/182 cluster (miR-183C) knockout mice exhibit decreased severity of Pseudomonas aeruginosa (PA)-induced keratitis. This study tests the hypothesis that prophylactic knockdown of miR-183C ameliorates PA keratitis indicative of a therapeutic potential. Methods: Eight-week-old miR-183C wild-type and C57BL/6J inbred mice were used. Locked nucleic acid-modified anti-miR-183C or negative control oligoribonucleotides with scrambled sequences (NC ORNs) were injected subconjunctivally 1 day before and then topically applied once daily for 5 days post-infection (dpi) (strain 19660). Corneal disease was graded at 1, 3, and 5 dpi. Corneas were harvested for RT-PCR, ELISA, immunofluorescence (IF), myeloperoxidase and plate count assays, and flow cytometry. Corneal nerve density was evaluated in flatmounted corneas by IF staining with anti-ß-III tubulin antibody. Results: Anti-miR-183C downregulated miR-183C in the cornea. It resulted in an increase in IL-1ß at 1 dpi, which was decreased at 5 dpi; fewer polymorphonuclear leukocytes (PMNs) at 5 dpi; lower viable bacterial plate count at both 1 and 5 dpi; increased percentages of MHCII+ macrophages (Mϕ) and dendritic cells (DCs), consistent with enhanced activation/maturation; and decreased severity of PA keratitis. Anti-miR-183C treatment in the cornea of naïve mice resulted in a transient reduction of corneal nerve density, which was fully recovered one week after the last anti-miR application. miR-183C targets repulsive axon-guidance receptor molecule Neuropilin 1, which may mediate the effect of anti-miR-183C on corneal nerve regression. Conclusions: Prophylactic miR-183C knockdown is protective against PA keratitis through its regulation of innate immunity, corneal innervation, and neuroimmune interactions.


Asunto(s)
Úlcera de la Córnea/prevención & control , Infecciones Bacterianas del Ojo/prevención & control , Regulación de la Expresión Génica/fisiología , MicroARNs/genética , Infecciones por Pseudomonas/prevención & control , Animales , Úlcera de la Córnea/genética , Úlcera de la Córnea/metabolismo , Citocinas/metabolismo , Ensayo de Inmunoadsorción Enzimática , Infecciones Bacterianas del Ojo/genética , Infecciones Bacterianas del Ojo/metabolismo , Femenino , Citometría de Flujo , Técnicas de Silenciamiento del Gen , Inmunidad Innata , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Fluorescente , Neutrófilos/fisiología , Infecciones por Pseudomonas/genética , Infecciones por Pseudomonas/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Transfección
9.
Exp Eye Res ; 211: 108750, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34481822

RESUMEN

Pseudomonas aeruginosa (P. aeruginosa) keratitis, a worldwide leading cause of corneal perforation and blindness, which is associated with contact lens usage. Increasing evidence has indicated that pyroptosis, a novel proinflammatory programmed cell death, is linked with ocular diseases, little is known about the role of noncanonical pyroptosis in microbial keratitis. Here, we first indicated the involvement of noncanonical pyroptosis in P. aeruginosa keratitis and investigated whether wedelolactone (WDL), a major active component of Eclipta prostrate known to target caspase-11, could alleviate P. aeruginosa keratitis development. We found the expression of caspase-4/5/11 and cleaved GSDMD in corneas of P. aeruginosa keratitis patients, animal models and lipopolysaccharide (LPS)-induced primary cultured human corneal keratocytes (piHCKs) were increased. Combining ciprofloxacin with WDL significantly ameliorated the severity of P. aeruginosa keratitis, as manifested by decreased inflammatory responses and reduced corneal epithelial defects. Consistent with these findings, WDL also dose-dependently alleviated LPS-induced noncanonical pyroptosis by reversing the increased expression of caspase-4/5 and GSDMD in piHCKs. In summary, our results demonstrated that by targeting the activation of caspase-4/5/11, wedelolactone inhibited the development of P. aeruginosa keratitis and suppressed the release of proinflammatory cytokines. Wedelolactone may be a promising anti-inflammatory candidate to combat P. aeruginosa keratitis.


Asunto(s)
Caspasas/metabolismo , Lesiones de la Cornea/prevención & control , Úlcera de la Córnea/prevención & control , Cumarinas/uso terapéutico , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Proteínas de Unión a Fosfato/metabolismo , Piroptosis/efectos de los fármacos , Animales , Western Blotting , Caspasas Iniciadoras/metabolismo , Proliferación Celular , Lesiones de la Cornea/metabolismo , Lesiones de la Cornea/microbiología , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Infecciones Bacterianas del Ojo/metabolismo , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/prevención & control , Humanos , Interleucina-18/metabolismo , Interleucina-1beta/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Masculino , Microscopía Fluorescente , Infecciones por Pseudomonas/metabolismo , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/prevención & control , Pseudomonas aeruginosa , Ratas Sprague-Dawley , Reacción en Cadena en Tiempo Real de la Polimerasa
10.
Int J Mol Sci ; 22(16)2021 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-34445684

RESUMEN

The shape and transparency of the cornea are essential for clear vision. However, its location at the ocular surface renders the cornea vulnerable to pathogenic microorganisms in the external environment. Pseudomonas aeruginosa and Staphylococcus aureus are two such microorganisms and are responsible for most cases of bacterial keratitis. The development of antimicrobial agents has allowed the successful treatment of bacterial keratitis if the infection is diagnosed promptly. However, no effective medical treatment is available after progression to corneal ulcer, which is characterized by excessive degradation of collagen in the corneal stroma and can lead to corneal perforation and corneal blindness. This collagen degradation is mediated by both infecting bacteria and corneal fibroblasts themselves, with a urokinase-type plasminogen activator (uPA)-plasmin-matrix metalloproteinase (MMP) cascade playing a central role in collagen destruction by the host cells. Bacterial factors stimulate the production by corneal fibroblasts of both uPA and pro-MMPs, released uPA mediates the conversion of plasminogen in the extracellular environment to plasmin, and plasmin mediates the conversion of secreted pro-MMPs to the active form of these enzymes, which then degrade stromal collagen. Bacterial factors also stimulate expression by corneal fibroblasts of the chemokine interleukin-8 and the adhesion molecule ICAM-1, both of which contribute to recruitment and activation of polymorphonuclear neutrophils, and these cells then further stimulate corneal fibroblasts via the secretion of interleukin-1. At this stage of the disease, bacteria are no longer necessary for collagen degradation. In this review, we discuss the pivotal role of corneal fibroblasts in corneal ulcer associated with infection by P. aeruginosa or S. aureus as well as the development of potential new modes of treatment for this condition.


Asunto(s)
Úlcera de la Córnea/metabolismo , Fibroblastos/metabolismo , Queratitis/microbiología , Animales , Colágeno/metabolismo , Córnea/metabolismo , Córnea/fisiología , Sustancia Propia/metabolismo , Úlcera de la Córnea/etiología , Úlcera de la Córnea/microbiología , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/fisiopatología , Fibrinolisina/metabolismo , Humanos , Metaloproteinasas de la Matriz/metabolismo , Plasminógeno/metabolismo , Activadores Plasminogénicos/metabolismo , Pseudomonas aeruginosa/metabolismo , Pseudomonas aeruginosa/patogenicidad , Staphylococcus aureus/metabolismo , Staphylococcus aureus/patogenicidad , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
11.
Exp Eye Res ; 207: 108581, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33865843

RESUMEN

Fungal keratitis (FK) pathology is driven by both fungal growth and inflammation within the corneal stroma. Standard in vitro infection models ̶ involving co-culture of the pathogen and the corneal cells in tissue culture medium ̶ are sufficient to probe host responses to the fungus; however, they lack the physiological structure and nutrient composition of the stroma to accurately study fungal invasiveness and metabolic processes. We therefore sought to develop a culture model of FK that would allow for both host and fungal cell biology to be evaluated in parallel. Towards this end, we employed a previously described system in which primary human cornea fibroblasts (HCFs) are cultured on transwell membranes, whereupon they secrete a three-dimensional (3D) collagen matrix that resembles the human stroma. We demonstrated that two common mold agents of FK, Fusarium petroliphilum and Aspergillus fumigatus, penetrated into these constructs and caused a disruption of the collagen matrix that is characteristic of infection. HCF morphology appeared altered in the presence of fungus and electron microscopy revealed a clear internalization of fungal spores into these cells. Consistent with this apparent phagocyte-like activity of the HCFs, mRNA and protein levels for several pro-inflammatory cytokines/chemokines (including TNFα, IL-1ß, IL-6, and IL-8) were significantly upregulated compared to uninfected samples. We similarly found an upregulation of several HCF metalloproteases (MMPs), which are enzymes that breakdown collagen during wound healing and may further activate pro-inflammatory signaling molecules. Finally, several fungal collagenase genes were upregulated during growth in the constructs relative to growth in tissue culture media alone, suggesting a fungal metabolic shift towards protein catabolism. Taken together, our results indicate that this 3D-stromal model provides a physiologically relevant system to study host and fungal cell pathobiology during FK.


Asunto(s)
Aspergilosis/microbiología , Queratocitos de la Córnea/microbiología , Úlcera de la Córnea/microbiología , Infecciones Fúngicas del Ojo/microbiología , Fusariosis/microbiología , Interacciones Huésped-Patógeno/fisiología , Animales , Aspergilosis/metabolismo , Aspergilosis/patología , Aspergillus fumigatus/fisiología , Técnicas de Cultivo de Célula , Queratocitos de la Córnea/metabolismo , Sustancia Propia/metabolismo , Sustancia Propia/microbiología , Sustancia Propia/ultraestructura , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/patología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Infecciones Fúngicas del Ojo/metabolismo , Infecciones Fúngicas del Ojo/patología , Fusariosis/metabolismo , Fusariosis/patología , Fusarium/fisiología , Humanos , Masculino , Metaloproteinasas de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Microscopía Electrónica de Transmisión , Reacción en Cadena en Tiempo Real de la Polimerasa
12.
Exp Eye Res ; 205: 108509, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33647271

RESUMEN

Mooren's ulcer (MU) is a refractory autoimmune corneal ulcer with a high recurrence rate. So far, its molecular profiles and pathomechanisms remain largely unknown. Therefore, we aim to characterize the protein profiles of MU specimens by data-independent-acquisition (DIA) mass spectrometry (MS), and to define the functions of differentially-expressed proteins (DEPs). Through LC-MS/MS, 550 DEPs were identified between MU biopsies and age-matched controls (Ctrl). KEGG analysis revealed that the significantly enriched pathways of the up-regulated proteins mainly covered lysosomes, antigen processing and presentation, and phagosomes. We subsequently validated the expressions of the selected candidates using parallel-reaction-monitoring (PRM)-based MS and immunohistochemistry (IHC), including cathepsins, TIMP3, MMP-10, MYOC, PIGR, CD74, CAT, SOD2, and SOD3. Moreover, immunoglobulin (Ig) components and B lymphocytes associated proteins MZB1, HSPA5, and LAP3 in MU were significantly increased and validated by PRM-based MS and IHC. The remarkable enrichment of neutrophil extracellular traps (NETs) components in MU samples was also identified and determined. The up-regulated Ig components and NETs components suggested that B lymphocytes and neutrophils participated in the immunopathology of MU. Importantly, we also identified and validated much more expression of peptidyl arginine deiminase 4 (PADI4) in MU samples. The double-immunofluorescence staining showed the co-localization of citrulline residues with MPO, NE, and IgG in MU samples. These results indicated the presences of PADI4-mediated citrullination modification and anti-citrullinated protein antibodies (ACPAs) in MU samples. Our findings, for the first time, provide a global proteomic signature of MU, which may open a new avenue towards disease pathology and therapeutics.


Asunto(s)
Úlcera de la Córnea/etiología , Úlcera de la Córnea/metabolismo , Proteínas del Ojo/metabolismo , Western Blotting , Cromatografía Líquida de Alta Presión , Biología Computacional , Chaperón BiP del Retículo Endoplásmico , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Inmunohistoquímica , Análisis de Componente Principal , Proteómica/métodos , Espectrometría de Masas en Tándem
13.
Signal Transduct Target Ther ; 6(1): 5, 2021 01 08.
Artículo en Inglés | MEDLINE | ID: mdl-33414365

RESUMEN

Forkhead box C1 (FOXC1) is required for neural crest and ocular development, and mutations in FOXC1 lead to inherited Axenfeld-Rieger syndrome. Here, we find that FOXC1 and paired box 6 (PAX6) are co-expressed in the human limbus and central corneal epithelium. Deficiency of FOXC1 and alternation in epithelial features occur in patients with corneal ulcers. FOXC1 governs the fate of the corneal epithelium by directly binding to lineage-specific open promoters or enhancers marked by H3K4me2. FOXC1 depletion not only activates the keratinization pathway and reprograms corneal epithelial cells into skin-like epithelial cells, but also disrupts the collagen metabolic process and interferon signaling pathways. Loss of interferon regulatory factor 1 and PAX6 induced by FOXC1 dysfunction is linked to the corneal ulcer. Collectively, our results reveal a FOXC1-mediated regulatory network responsible for corneal epithelial homeostasis and provide a potential therapeutic target for corneal ulcer.


Asunto(s)
Úlcera de la Córnea/metabolismo , Células Epiteliales/metabolismo , Epitelio Corneal/metabolismo , Factores de Transcripción Forkhead/deficiencia , Células Cultivadas , Úlcera de la Córnea/genética , Úlcera de la Córnea/patología , Células Epiteliales/patología , Epitelio Corneal/patología , Factores de Transcripción Forkhead/metabolismo , Humanos , Factor de Transcripción PAX6/genética , Factor de Transcripción PAX6/metabolismo
14.
Cornea ; 40(5): 656-658, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-32826643

RESUMEN

PURPOSE: To describe a case of nivolumab-induced ulcerative keratitis rapidly recovering on topical steroid treatment and to determine changes in cytokine levels in the tear fluid caused by nivolumab. METHODS: We report a 34-year-old man receiving nivolumab for metastasized melanoma with severe dry eye symptoms and a persistent corneal epithelial defect. Levels of cytokine and matrix metalloproteinase in tear fluid were measured by multiplex immunoassays. RESULTS: The corneal epithelial defect failed to recover for antiviral and lubrication therapy but resolved within 48 hours after topical steroid therapy was initiated. No recurrence of corneal ulceration was observed with intermittent topical steroid therapy during the remaining period of nivolumab treatment. No Sjögren disease-related autoantibodies were detected in the patient's serum. The levels of inflammatory cytokines and matrix metalloproteinases in the tear fluid were markedly elevated after nivolumab treatment. CONCLUSIONS: Our observations suggest that nivolumab treatment induces a local autoimmune ocular surface disorder resulting in corneal ulceration that promptly resolves using steroid eye drops. The integrity of the corneal epithelial layer can be sustained using intermittent topical steroid therapy in patients receiving nivolumab.


Asunto(s)
Úlcera de la Córnea/inducido químicamente , Síndromes de Ojo Seco/inducido químicamente , Inhibidores de Puntos de Control Inmunológico/efectos adversos , Nivolumab/efectos adversos , Aciclovir/uso terapéutico , Adulto , Antivirales/uso terapéutico , Úlcera de la Córnea/diagnóstico , Úlcera de la Córnea/tratamiento farmacológico , Úlcera de la Córnea/metabolismo , Citocinas/metabolismo , Síndromes de Ojo Seco/diagnóstico , Síndromes de Ojo Seco/tratamiento farmacológico , Síndromes de Ojo Seco/metabolismo , Humanos , Inmunoensayo , Masculino , Metaloproteinasas de la Matriz/metabolismo , Melanoma/tratamiento farmacológico , Melanoma/secundario , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Lágrimas/metabolismo
15.
Ocul Immunol Inflamm ; 29(7-8): 1648-1655, 2021 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-32644867

RESUMEN

PURPOSE: To evaluate the efficacy of CXL in treating fungal keratitis as an adjuvant therapy. METHODS: Detailed clinical examination microbiological investigation was performed. Twenty fungal keratitis patients were recruited and randomized into two groups: group 1 (n= 11, standard antifungal), group 2 (n=9, corneal collagen crosslinking with standard antifungal). Corneal scraping and tear samples collected were subjected to real-time PCR targeting ITS, TLR analysis and cytokine analysis. RESULTS: The mean time for complete resolution of ulcer for group 2 was significantly shorter compared to group 1 and the final mean BCVA was better for group 2. Expression of IL-1ß, IL-8, IFN-γ significantly decreased immediately post CXL in group 2 patients. Significant downregulation of TLR 6, TLR-3, TLR-4 was observed 3-days post CXL compared to group 1 patients. CONCLUSION: Adjuvant effect of CXL was significant in treating fungal keratitis compared to standalone antifungal treatment.


Asunto(s)
Colágeno/metabolismo , Sustancia Propia/efectos de los fármacos , Úlcera de la Córnea/tratamiento farmacológico , Reactivos de Enlaces Cruzados , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Adulto , Antifúngicos/uso terapéutico , Terapia Combinada , Sustancia Propia/metabolismo , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Reactivos de Enlaces Cruzados/uso terapéutico , Citocinas/metabolismo , Infecciones Fúngicas del Ojo/metabolismo , Infecciones Fúngicas del Ojo/microbiología , Femenino , Humanos , India , Masculino , Persona de Mediana Edad , Oftalmología , Fotoquimioterapia/métodos , Riboflavina/uso terapéutico , Centros de Atención Terciaria , Receptores Toll-Like/metabolismo , Resultado del Tratamiento , Rayos Ultravioleta
16.
Cornea ; 40(7): 837-841, 2021 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-33079921

RESUMEN

PURPOSE: To determine whether there is a benefit to adjuvant corneal cross-linking (CXL) for bacterial keratitis. METHODS: This is an outcome-masked, randomized controlled clinical trial. Consecutive patients presenting with a smear-positive bacterial ulcer at Aravind Eye Hospitals at Madurai, Pondicherry, and Coimbatore in India were enrolled. Study eyes were randomized to topical moxifloxacin 0.5% or topical moxifloxacin 0.5% plus CXL. The primary outcome of the trial was microbiological cure at 24 hours on repeat culture. Secondary outcomes included best spectacle corrected visual acuity at 3 weeks and 3 months, percentage of study participants with epithelial healing at 3 weeks and 3 months, infiltrate and/or scar size at 3 weeks and 3 months, 3-day smear and culture, and adverse events. RESULTS: Those randomized to CXL had 0.60 decreased odds of culture positivity at 24 hours (95% confidence interval [CI]: 0.10-3.50; P = 0.65), 0.9 logarithm of the minimum angle of resolution lines worse visual acuity (95% CI: -2.8 to 4.6; P = 0.63), and 0.41-mm larger scar size (95% CI: -0.48 to 1.30; P = 0.38) at 3 months. We note fewer corneal perforations or need for therapeutic penetrating keratoplasty in the CXL group. CONCLUSIONS: We were unable to confirm a benefit to adjuvant CXL in the primary treatment of moderate bacterial keratitis. However, CXL may reduce culture positivity and complication rates; therefore, a larger trial to fully evaluate this is warranted. TRIAL REGISTRATION: NCT02570321.


Asunto(s)
Úlcera de la Córnea/tratamiento farmacológico , Reactivos de Enlaces Cruzados/uso terapéutico , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Anciano , Antibacterianos/uso terapéutico , Bacterias/aislamiento & purificación , Colágeno/metabolismo , Terapia Combinada , Sustancia Propia/efectos de los fármacos , Sustancia Propia/metabolismo , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Úlcera de la Córnea/fisiopatología , Infecciones Bacterianas del Ojo/metabolismo , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Moxifloxacino/uso terapéutico , Riboflavina/uso terapéutico , Resultado del Tratamiento , Rayos Ultravioleta , Agudeza Visual/fisiología
17.
Invest Ophthalmol Vis Sci ; 61(5): 26, 2020 05 11.
Artículo en Inglés | MEDLINE | ID: mdl-32416603

RESUMEN

Purpose: IFN-stimulated gene (ISG) 15 is a type 1 IFN-induced protein and known to modify target proteins in a manner similar to ubiquitylation (protein conjugation by ISG15 is termed ISGylation). We sought to determine the role of ISG15 and its underlying mechanisms in corneal innate immune defense against Pseudomonas aeruginosa keratitis. Methods: ISG15 expression in cultured human corneal epithelial cells (HCECs) and mouse corneas was determined by PCR and Western blot analysis. Gene knockout mice were used to define the role of ISG15 signaling in controlling the severity of P. aeruginosa keratitis, which was assessed with photographing, clinical scoring, bacterial counting, myeloperoxidase assay, and quantitative PCR determination of cytokine expression. Integrin LFA-1 inhibitor was used to assess its involvement of ISG15 signaling in P. aeruginosa-infected corneas. Results: Heat-killed P. aeruginosa induced ISG15 expression in cultured HCECs and accumulation in the conditioned media. Isg15 deficiency accelerated keratitis progress, suppressed IFNγ and CXCL10, and promoted IL-1ß while exhibiting no effects on IFNα expression. Moreover, exogenous ISG15 protected the corneas of wild-type mice from P. aeruginosa infection while markedly reducing the severity of P. aeruginosa keratitis in type 1 IFN-receptor knockout mice. Exogenous ISG15 increased bacteriostatic activity of B6 mouse corneal homogenates, and inhibition of LFA-1 exacerbated the severity of and abolished protective effects of ISG15 on P. aeruginosa keratitis. Conclusions: Type 1 INF-induced ISG15 regulates the innate immune response and greatly reduces the susceptibility of B6 mouse corneas to P. aeruginosa infection in an LFA-1-dependent manner.


Asunto(s)
Úlcera de la Córnea/inmunología , Citocinas/fisiología , Infecciones Bacterianas del Ojo/inmunología , Inmunidad Innata/fisiología , Infecciones por Pseudomonas/inmunología , Ubiquitinas/fisiología , Animales , Carga Bacteriana , Western Blotting , Células Cultivadas , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/fisiopatología , Citocinas/metabolismo , Epitelio Corneal/metabolismo , Infecciones Bacterianas del Ojo/metabolismo , Infecciones Bacterianas del Ojo/fisiopatología , Regulación de la Expresión Génica/fisiología , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Peroxidasa/metabolismo , Infecciones por Pseudomonas/metabolismo , Infecciones por Pseudomonas/fisiopatología , Reacción en Cadena en Tiempo Real de la Polimerasa , Transducción de Señal/fisiología
18.
Invest Ophthalmol Vis Sci ; 61(4): 23, 2020 04 09.
Artículo en Inglés | MEDLINE | ID: mdl-32301974

RESUMEN

Purpose: To determine the effects of airborne particulate matter (PM) <2.5 µm in vitro and on the normal and Pseudomonas aeruginosa (PA)-infected cornea. Methods: An MTT viability assay tested the effects of PM2.5 on mouse corneal epithelial cells (MCEC) and human corneal epithelial cells (HCET). MCEC were tested for reactive oxygen species using a 2',7'-dichlorodihydrofluorescein assay; RT-PCR determined mRNA levels of inflammatory and oxidative stress markers in MCEC (HMGB1, toll-like receptor 2, IL-1ß, CXCL2, GPX1, GPX2, GR1, superoxide dismutase 2, and heme oxygenase 1) and HCET (high mobility group box 1, CXCL2, and IL-1ß). C57BL/6 mice also were infected and after 6 hours, the PM2.5 was topically applied. Disease was graded by clinical score and evaluated by histology, plate count, myeloperoxidase assay, RT-PCR, ELISA, and Western blot. Results: After PM2.5 (25-200 µg/mL), 80% to 90% of MCEC and HCET were viable and PM exposure increased reactive oxygen species in MCEC and mRNA expression levels for inflammatory and oxidative stress markers in mouse and human cells. In vivo, the cornea of PA+PM2.5 exposed mice exhibited earlier perforation over PA alone (confirmed histologically). In cornea, plate counts were increased after PA+PM2.5, whereas myeloperoxidase activity was significantly increased after PA+PM2.5 over other groups. The mRNA levels for several proinflammatory and oxidative stress markers were increased in the cornea in the PA+PM2.5 over other groups; protein levels were elevated for high mobility group box 1, but not toll-like receptor 4 or glutathione reductase 1. Uninfected corneas treated with PM2.5 did not differ from normal. Conclusions: PM2.5 triggers reactive oxygen species, upregulates mRNA levels of oxidative stress, inflammatory markers, and high mobility group box 1 protein, contributing to perforation in PA-infected corneas.


Asunto(s)
Epitelio Corneal/efectos de los fármacos , Homeostasis/efectos de los fármacos , Inmunidad/efectos de los fármacos , Material Particulado/farmacología , Animales , Biomarcadores/metabolismo , Western Blotting , Supervivencia Celular , Células Cultivadas , Úlcera de la Córnea/tratamiento farmacológico , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/patología , Ensayo de Inmunoadsorción Enzimática , Epitelio Corneal/metabolismo , Epitelio Corneal/patología , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Infecciones Bacterianas del Ojo/metabolismo , Infecciones Bacterianas del Ojo/patología , Femenino , Humanos , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/fisiología , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/metabolismo , Infecciones por Pseudomonas/patología , ARN Mensajero/genética , Especies Reactivas de Oxígeno/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa
19.
Invest Ophthalmol Vis Sci ; 61(4): 17, 2020 04 09.
Artículo en Inglés | MEDLINE | ID: mdl-32298434

RESUMEN

Purpose: Extended contact lens (CL) wear predisposes the wearer to Pseudomonas aeruginosa infection of the cornea, but the mechanism involved remains incompletely understood. The purpose of this study was to investigate the role of the stress hormone norepinephrine (NE) in the pathogenesis of CL-induced P. aeruginosa keratitis. Methods: A total 195 adult C57BL/6 mice were used in this study. Corneal NE content was measured after 48 hours of sterile CL wear in mice. The effect of NE on P. aeruginosa adhesion and biofilm formation on the CL surface was examined in vitro. Moreover, mouse eyes were covered with P. aeruginosa-contaminated CLs, and either 500-µM NE was topically applied or the eyes were subconjunctivally injected with 100 µg of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) to deplete local NE. Clinical scores, neutrophil infiltration, proinflammatory cytokine levels, and bacterial load on the corneas and CLs were evaluated. Results: Corneal NE content was elevated with extended CL wear in mice. In vitro, NE promoted the adhesion and biofilm formation of P. aeruginosa on the CL surface. In mice, topical application of NE aggravated P. aeruginosa infection, accompanied with increased clinical scores, neutrophil infiltration, proinflammatory cytokine expression, and bacterial burden on the corneas and CLs. However, pre-depletion of local NE with DSP-4 significantly alleviated the severity of P. aeruginosa keratitis. Conclusions: Extended CL wear elevates corneal NE content, which promotes the pathogenesis of CL-induced P. aeruginosa keratitis in mice. Targeting NE may provide a potential strategy for the treatment of CL-related corneal infection caused by P. aeruginosa.


Asunto(s)
Lentes de Contacto de Uso Prolongado/efectos adversos , Úlcera de la Córnea/metabolismo , Infecciones Bacterianas del Ojo/metabolismo , Norepinefrina/metabolismo , Infecciones por Pseudomonas/metabolismo , Animales , Adhesión Bacteriana/fisiología , Carga Bacteriana , Técnicas de Cocultivo , Úlcera de la Córnea/etiología , Úlcera de la Córnea/microbiología , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Infecciones Bacterianas del Ojo/etiología , Infecciones Bacterianas del Ojo/microbiología , Técnica del Anticuerpo Fluorescente Indirecta , Ratones , Ratones Endogámicos C57BL , Infecciones por Pseudomonas/etiología , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/fisiología
20.
Middle East Afr J Ophthalmol ; 27(4): 204-209, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33814816

RESUMEN

PURPOSE: To evaluate the effectiveness of ultraviolet (UV)-A/Riboflavin corneal cross-linking (CXL) for the treatment of the refractory cases of fungal keratitis. METHODS: In this prospective interventional study, 9 patients with the diagnosis of fungal keratitis that were referred to our emergency eye center were included. These patients were resistant to conventional treatment and underwent therapeutic UV-A/Riboflavin CXL. Response to the treatment was considered as good if rapid epithelialization and rapid decrease in stromal infiltration was occurred after PACK-CXL, and poor when the emergency transplantation was necessary to eradicate the infection. RESULTS: Nine patients treated with CXL due to recalcitrant fungal keratitis. Culture of the corneal scrapings showed Aspergillus species in 4 patients, Candida albicans in 1 patient and Fusarium species in the remainder of them. CXL was performed from 1 to 20 days after the presentation of corneal ulcers (Mean: 9.12 ± 4.02; range: 5-20 days). Postoperatively, the mean time to epithelialization was 14.25 ± 2.38 days, and mean time to resolution of stromal infiltration was 22.5 ± 7.29 days, in responsive cases. Four out of 9 eyes showed good response, and five patients showed no response, and corneal transplantation was performed to eradicate the infection. There was no statistically significant difference in mean depth of infiltration and mean size of ulcer between responsive and unresponsive patients (P = 0.86 and 0.08, respectively). CONCLUSION: Although UV-A/Riboflavin CXL is not a definite treatment for all of the fungal keratitis, it seems promising in the management of some refractory cases.


Asunto(s)
Colágeno/metabolismo , Úlcera de la Córnea/tratamiento farmacológico , Reactivos de Enlaces Cruzados , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Riboflavina/uso terapéutico , Adulto , Anciano , Sustancia Propia/metabolismo , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/microbiología , Infecciones Fúngicas del Ojo/metabolismo , Infecciones Fúngicas del Ojo/microbiología , Humanos , Masculino , Persona de Mediana Edad , Fotoquimioterapia/métodos , Estudios Prospectivos , Microscopía con Lámpara de Hendidura , Rayos Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...